Laboratory Considerations When Developing Multiple Myeloma Trials


Join ICON’s experts Dr. Marc Golightly, PhD and Domenica Gandini as they speak about considerations when developing Multiple Myeloma trials. With the growing number of therapeutics being developed for Multiple Myeloma, the need for laboratory expert

View More
View Less

Share this video